# Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

> **NCT00414193** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 1000 (actual)

## Conditions studied

- Bacteremia
- AmpC Beta-lactamase

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00414193
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2018-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414193, "Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00414193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*